View

The Study

Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease

In simple terms

This study is like a fair race between two groups of people with heart disease, where one group tries to get their 'bad' cholesterol really low and the other aims a bit higher. Because people were randomly assigned, we can say that the lower target probably caused fewer heart problems over 3 years.

83%

Analysis score

83/ 90

Maximum 90 for a randomized controlled trial.

Where the score came from

Reporting75
Methodology81
Publication100
Statistical77
Study type (basis of the score)
Randomized Controlled Trial
Level 1b - Individual RCT
What’s the bottom line?

Doctors wanted to see if aiming for a really low cholesterol number helps prevent heart problems in people who already have heart disease.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Randomized Trials
Level 1b
83

83 / 100

Quality score

Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.

Can establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

  1. 1Yes, this is meaningful — preventing one heart event for every 32 people treated over 3 years is a strong benefit with no extra harm.
  2. 233% fewer heart problems happened in the group that aimed for less than 55 mg/dL of LDL cholesterol.
  3. 36.6% got sick vs.
  4. 49.7%.
  5. 5No more side effects were seen, and kidney stress signs were lower.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data

Publication

Journal

New England Journal of Medicine

Year

2026

Authors

Yong-Joon Lee, Seung-Jun Lee, Jin Won Kim, Sang-Hyup Lee, Gwang-Sil Kim, Jae Hyoung Park, Jin-Man Cho, W. Kang, H. Yoon, W. H. Kim, Seung-Jin Lee, Jin Bae Lee, Ji-Yong Jang, Sanghoon Shin, I. H. Park, S. Kwon, Sunwon Kim, Sungwoo Hong, Chul-Min Ahn, Jung-Sun Kim, Y. Ko, D. Choi, M. Hong, Y. Jang, Byeong‐Keuk Kim

Related Content

Claims (6)

Assertion

If you've already had heart problems, keeping your 'bad' cholesterol really low—below 55—might help prevent future heart attacks or strokes compared to aiming for a higher level.

Causal
Read analysis
Assertion

For people with heart disease from clogged arteries, getting their bad cholesterol down to around 56 doesn’t cause more serious side effects than staying at 66, and it’s safe to keep it that low for at least three years.

Quantitative
Read analysis
Assertion

For people who already have heart disease, aiming to get their 'bad' cholesterol (LDL) below 55 mg/dL cuts their risk of serious heart problems by about one-third over three years compared to aiming for below 70 mg/dL — and it doesn’t seem to cause more side effects.

Causal
Read analysis
Assertion

If you have heart disease from clogged arteries, getting your bad cholesterol down to around 56 mg/dL instead of 66 mg/dL can cut your risk of heart attacks or strokes by about a third over three years. For every 32 people treated this way, one person avoids a major heart problem.

Causal
Read analysis
Assertion

For people with heart disease from clogged arteries, keeping bad cholesterol really low—below 55—might be better for your kidneys than keeping it just under 70, especially if you're getting procedures to open up blood vessels.

Causal
Read analysis
Assertion

If you've had heart problems before, aiming to get your 'bad' cholesterol really low—below 55—cuts your risk of another heart issue by about a third compared to keeping it just under 70.

Causal
Read analysis
Fit Body Science verdict — we translate health studies into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.